Print

Astrogenetix and NASA Sign Agreement to Continue Developing Medicines in Space to Save Lives on Earth  
2/8/2012 10:02:08 AM

AUSTIN, Texas, Feb. 8, 2012 (GLOBE NEWSWIRE) -- Astrogenetix Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC), has entered into a Space Act Agreement (SAA) with NASA, (National Aeronautics and Space Administration). This SAA commits to providing the critical resources needed to continue utilizing the International Space Station (ISS) and to further the development of important on-orbit microgravity vaccines and therapeutic drug experiments.